JBJ-04-125-02
Product Specifications
CAS Number
2060610-53-7
Target
JAK, EGFR
Related Pathways
JAK/STAT signaling, Angiogenesis, Stem Cells, Chromatin/Epigenetic, Tyrosine Kinase/Adaptors
Bioactivity
JBJ-04-125-02 can inhibit cancer cell proliferation and EGFRL858R/T790M/C797S signaling. JBJ-04-125-02 has anti-tumor activities. JBJ-04-125-02 is a potent, mutant-selective, allosteric and orally active EGFR inhibitor with an IC50 of 0.26 nM for EGFRL858R/T790M.
Smiles
[C@@H](C(NC1=NC=CS1)=O)(N2C(=O)C=3C(C2)=CC=C(C3)C4=CC=C(C=C4)N5CCNCC5)C6=C(O)C=CC(F)=C6
Molecular Formula
C29H26FN5O3S
Molecular Weight
543.61
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL713711V 500 µL Each
Nob1 Rat shRNA Lentiviral Particle (Locus ID 291996)
Sign In for Pricing
View Details 
MBS7067062 Inquire
Recombinant Salmonella newport Probable intracellular septation protein A (yciB), partial
Sign In for Pricing
View Details